Press release
Gelt and Ascent Group Announce Webinar on Tax-Advantaged Real Estate Investing for High-Earning Professionals
The webinar is tailored for busy professionals, including physicians and high-net-worth investors, who are seeking to diversify their portfolios and minimize tax burdens while focusing on wealth-building through passive real estate investments. Attendees will gain access to expert insights on enhancing tax efficiency and leveraging strategic investments to meet long-term financial goals.
Key Highlights of the Webinar:
- Tailored Tax Strategies for Physicians and Investors: Gain insights into aligning tax planning with professional roles, income types, and geographical considerations.
- Maximizing Real Estate Investment Tax Benefits: Learn how to maximize tax savings and what to expect throughout the lifecycle of real estate investments
- Simplifying Complex Tax Scenarios: Explore solutions to manage the complexities of multi-state K-1 filings often encountered in syndications and real estate funds.
- Exclusive Offers and Resources: Attendees receive a complimentary consultation with Gelt and a 10% discount on Gelt's tax services
Why It Matters:
High-earning professionals often face significant challenges in optimizing tax efficiency due to complex regulations and time constraints. This webinar provides straightforward strategies to simplify these complexities, enabling attendees to focus on their careers while building lasting wealth.
"Physicians and investors work hard for their income, and they deserve strategies that help them keep more of it. This webinar is designed to provide clarity and confidence, enabling our audience to take control of their financial future," said Tal Binder, CEO and Founder of Gelt.
"As a CPA, I see firsthand how the right tax strategies can transform financial outcomes. Attendees will leave this webinar with a clear understanding of how real estate investments and strategic tax planning can be used to create opportunities for long-term success," added Rachel Richards, CPA and Head of Product at Gelt.
Pranay Parikh, Physician, Investor, and Partner at Ascent Group, emphasized, "This collaboration between Gelt and Ascent Group is about more than just tax planning. It's about equipping professionals with tools to achieve lasting financial freedom and peace of mind."
Webinar Registration:
This event is free to attend, but space is limited. Interested individuals can register at https://lnkd.in/eTXEg5_5.
For more information, visit https://www.joingelt.com/ or use the contact form [https://share.hsforms.com/1KGv6daLMQsGZ-IfBwCgASgdb71f]to learn more.
About Gelt:
Gelt combines technology-driven tax planning solutions with CPA expertise to deliver tailored strategies that maximize tax efficiency and long-term financial success.
About Ascent Group:
Ascent Group specializes in advanced investment strategies, providing high-net-worth professionals with insights to optimize their portfolios and financial outcomes.
Media Contact
Company Name: Society22 PR
Contact Person: Kodie Ustin
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=gelt-and-ascent-group-announce-webinar-on-taxadvantaged-real-estate-investing-for-highearning-professionals]
Country: United States
Website: https://www.joingelt.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gelt and Ascent Group Announce Webinar on Tax-Advantaged Real Estate Investing for High-Earning Professionals here
News-ID: 3789055 • Views: …
More Releases from ABNewswire
Graves Ophthalmopathy Market Growth to Surge During Forecast Period (2024-2034), …
The Key Graves Ophthalmopathy Companies in the market include - Immunovant Sciences GmbH, Horizon Pharma USA, Inc., Viridian Therapeutics, Inc., Tourmaline Bio, Inc., ACELYRIN Inc., Hoffmann-La Roche, Horizon Therapeutics USA, Inc., Lassen Therapeutics Inc., Novartis, Sling Therapeutics, Inc., Lassen Therapeutics, and others
The Graves Ophthalmopathy market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Graves Ophthalmopathy pipeline products will…
Neurotrophic Keratitis Market to Witness Promising Upswing by 2034, DelveInsight …
The Key Neurotrophic Keratitis Companies in the market include - Dompe Farmaceutici, BRIM Biotechnology, ReGenTree, LLC, Oyster Point Pharma, Inc., Syneos Health, Recordati Rare Diseases, MimeTech, Claris Biotherapeutics, and others.
DelveInsight's "Neurotrophic Keratitis Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Neurotrophic Keratitis, historical and forecasted epidemiology as well as the Neurotrophic Keratitis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United…
Metastatic Prostate Cancer Market Positioned for Accelerated Development Through …
The Key Metastatic Prostate Cancer Companies in the market include - Curium US LLC, Bayer, Hookipa Biotech GmbH, University Health Network, Merck Sharp & Dohme, Arvinas Androgen Receptor, UNICANCER, Aragon Pharmaceuticals, Mark Stein, Novartis, Orion Corporation, Janssen Research & Development, AstraZeneca, MedSIR, Aragon Pharmaceuticals, Janssen Research & Development, Telix Pharmaceuticals, Alliance Foundation Trials, Epizyme, Inc., Exelixis, and others.
DelveInsight's "Metastatic Prostate Cancer Market Insights, Epidemiology, and Market Forecast-2034 report offers an…
Prostate Cancer Pipeline and Competitive Landscape: 150+ Companies, 160+ Therapi …
Leading organizations including Curium, Merck, Telix Pharmaceuticals, Exelixis, AstraZeneca, AB Science, Lantheus, Pfizer, Jiangsu Hengrui Pharmaceuticals, Modra Pharmaceuticals, Bristol-Myers Squibb, Zenith Epigenetics, Xencor, Merus, Phosplatin Therapeutics, Laekna Therapeutics, Tavanta Therapeutics, Madison Vaccines, Taiho Pharmaceutical, Ipsen Biopharmaceuticals, LAVA Therapeutics, ESSA Pharma, Poseida Therapeutics, AbbVie, SL VAXiGEN, Nammi Therapeutics, BeiGene, DualityBio, and others.
The prostate cancer treatment arena is undergoing rapid transformation, with over 150 organizations actively working on novel therapies across multiple…
More Releases for Gelt
Gelt Raises $13M Series A to Expand AI-Powered Tax Solutions for Real Estate Inv …
Miami, FL - September 30, 2025 - Gelt [https://www.joingelt.com/], the first AI-native tax firm for investors and the Top 1% in the U.S., today announced it has raised $13 million in Series A [https://www.businesswire.com/news/home/20250930325477/en/Gelt-the-First-AI-Native-Tax-Firm-Raises-%2413M-in-Series-A-Funding-to-Transform-Tax-Strategy-Into-Year-Round-Wealth-Optimization], bringing its total funding to $21.2 million. Global investors, Zvi Limon of the Rimon Group, Vintage Investment Partners, and TLV Partners led the funding. As part of the launch, Yoram Tietz, former Managing Partner at EY…
Gelt Raises $13M Series A to Expand AI-Powered Tax Solutions for Wealth Managers …
Miami, FL - September 30, 2025 - Gelt [https://www.joingelt.com/], the first AI-native tax firm for investors and the Top 1% in the U.S., today announced it has raised $13 million in Series A [https://www.businesswire.com/news/home/20250930325477/en/Gelt-the-First-AI-Native-Tax-Firm-Raises-%2413M-in-Series-A-Funding-to-Transform-Tax-Strategy-Into-Year-Round-Wealth-Optimization], bringing its total funding to $21.2 million. Global investors, including Zvi Limon of the Rimon Group, Vintage Investment Partners, and TLV Partners, led the funding. As part of the launch, Yoram Tietz, former Managing Partner at…
